Solara Active Pharma Sciences Ltd
NSE:SOLARA

Watchlist Manager
Solara Active Pharma Sciences Ltd Logo
Solara Active Pharma Sciences Ltd
NSE:SOLARA
Watchlist
Price: 799.35 INR 4.98% Market Closed
Market Cap: 38.4B INR
Have any thoughts about
Solara Active Pharma Sciences Ltd?
Write Note

Intrinsic Value

The intrinsic value of one SOLARA stock under the Base Case scenario is 539.44 INR. Compared to the current market price of 799.35 INR, Solara Active Pharma Sciences Ltd is Overvalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SOLARA Intrinsic Value
539.44 INR
Overvaluation 33%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Solara Active Pharma Sciences Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SOLARA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SOLARA?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Solara Active Pharma Sciences Ltd

Provide an overview of the primary business activities
of Solara Active Pharma Sciences Ltd.

What unique competitive advantages
does Solara Active Pharma Sciences Ltd hold over its rivals?

What risks and challenges
does Solara Active Pharma Sciences Ltd face in the near future?

Has there been any significant insider trading activity
in Solara Active Pharma Sciences Ltd recently?

Summarize the latest earnings call
of Solara Active Pharma Sciences Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Solara Active Pharma Sciences Ltd.

Provide P/S
for Solara Active Pharma Sciences Ltd.

Provide P/E
for Solara Active Pharma Sciences Ltd.

Provide P/OCF
for Solara Active Pharma Sciences Ltd.

Provide P/FCFE
for Solara Active Pharma Sciences Ltd.

Provide P/B
for Solara Active Pharma Sciences Ltd.

Provide EV/S
for Solara Active Pharma Sciences Ltd.

Provide EV/GP
for Solara Active Pharma Sciences Ltd.

Provide EV/EBITDA
for Solara Active Pharma Sciences Ltd.

Provide EV/EBIT
for Solara Active Pharma Sciences Ltd.

Provide EV/OCF
for Solara Active Pharma Sciences Ltd.

Provide EV/FCFF
for Solara Active Pharma Sciences Ltd.

Provide EV/IC
for Solara Active Pharma Sciences Ltd.

Show me price targets
for Solara Active Pharma Sciences Ltd made by professional analysts.

What are the Revenue projections
for Solara Active Pharma Sciences Ltd?

How accurate were the past Revenue estimates
for Solara Active Pharma Sciences Ltd?

What are the Net Income projections
for Solara Active Pharma Sciences Ltd?

How accurate were the past Net Income estimates
for Solara Active Pharma Sciences Ltd?

What are the EPS projections
for Solara Active Pharma Sciences Ltd?

How accurate were the past EPS estimates
for Solara Active Pharma Sciences Ltd?

What are the EBIT projections
for Solara Active Pharma Sciences Ltd?

How accurate were the past EBIT estimates
for Solara Active Pharma Sciences Ltd?

Compare the revenue forecasts
for Solara Active Pharma Sciences Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Solara Active Pharma Sciences Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Solara Active Pharma Sciences Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Solara Active Pharma Sciences Ltd compared to its peers.

Compare the P/E ratios
of Solara Active Pharma Sciences Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Solara Active Pharma Sciences Ltd with its peers.

Analyze the financial leverage
of Solara Active Pharma Sciences Ltd compared to its main competitors.

Show all profitability ratios
for Solara Active Pharma Sciences Ltd.

Provide ROE
for Solara Active Pharma Sciences Ltd.

Provide ROA
for Solara Active Pharma Sciences Ltd.

Provide ROIC
for Solara Active Pharma Sciences Ltd.

Provide ROCE
for Solara Active Pharma Sciences Ltd.

Provide Gross Margin
for Solara Active Pharma Sciences Ltd.

Provide Operating Margin
for Solara Active Pharma Sciences Ltd.

Provide Net Margin
for Solara Active Pharma Sciences Ltd.

Provide FCF Margin
for Solara Active Pharma Sciences Ltd.

Show all solvency ratios
for Solara Active Pharma Sciences Ltd.

Provide D/E Ratio
for Solara Active Pharma Sciences Ltd.

Provide D/A Ratio
for Solara Active Pharma Sciences Ltd.

Provide Interest Coverage Ratio
for Solara Active Pharma Sciences Ltd.

Provide Altman Z-Score Ratio
for Solara Active Pharma Sciences Ltd.

Provide Quick Ratio
for Solara Active Pharma Sciences Ltd.

Provide Current Ratio
for Solara Active Pharma Sciences Ltd.

Provide Cash Ratio
for Solara Active Pharma Sciences Ltd.

What is the historical Revenue growth
over the last 5 years for Solara Active Pharma Sciences Ltd?

What is the historical Net Income growth
over the last 5 years for Solara Active Pharma Sciences Ltd?

What is the current Free Cash Flow
of Solara Active Pharma Sciences Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Solara Active Pharma Sciences Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Solara Active Pharma Sciences Ltd

Current Assets 7.6B
Cash & Short-Term Investments 180.7m
Receivables 3.8B
Other Current Assets 3.6B
Non-Current Assets 15.3B
Long-Term Investments 203.8m
PP&E 11B
Intangibles 4B
Other Non-Current Assets 98.7m
Current Liabilities 10.5B
Accounts Payable 2.8B
Accrued Liabilities 19.7m
Other Current Liabilities 7.7B
Non-Current Liabilities 1.6B
Long-Term Debt 973.2m
Other Non-Current Liabilities 581.1m
Efficiency

Earnings Waterfall
Solara Active Pharma Sciences Ltd

Revenue
12.2B INR
Cost of Revenue
-7.5B INR
Gross Profit
4.7B INR
Operating Expenses
-6.2B INR
Operating Income
-1.5B INR
Other Expenses
-3.9B INR
Net Income
-5.4B INR

Free Cash Flow Analysis
Solara Active Pharma Sciences Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

SOLARA Profitability Score
Profitability Due Diligence

Solara Active Pharma Sciences Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Negative 1-Year Revenue Growth
Negative 3-Years Revenue Growth
25/100
Profitability
Score

Solara Active Pharma Sciences Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

SOLARA Solvency Score
Solvency Due Diligence

Solara Active Pharma Sciences Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
41/100
Solvency
Score

Solara Active Pharma Sciences Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SOLARA Price Targets Summary
Solara Active Pharma Sciences Ltd

Wall Street analysts forecast SOLARA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SOLARA is 577.32 INR with a low forecast of 571.66 INR and a high forecast of 594.3 INR.

Lowest
Price Target
571.66 INR
28% Downside
Average
Price Target
577.32 INR
28% Downside
Highest
Price Target
594.3 INR
26% Downside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SOLARA?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SOLARA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

SOLARA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Solara Active Pharma Sciences Ltd Logo
Solara Active Pharma Sciences Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

38.4B INR

Dividend Yield

0%

Description

Solara Active Pharma Sciences Ltd. engages in the manufacture and development of active pharmaceutical ingredient. The company is headquartered in Chennai, Tamil Nadu. The company went IPO on 2018-06-27. The firm is involved in contract manufacturing and development services for global companies. Its commercial products include Aprepitant (Antiemetic), Brivaracetam (Antiepileptic), Bumetanide (Inj) (Loop Diuretic), Buspirone Hcl (Anxiolytic), Cevimeline Hydrochloride (Muscarinic Agonist), Cinacalcet Hydrochloride (Calcimimetic Agent), Citicoline Sodium (Anticonvulsant), Colchicine (Antigout Agent), Disulfiram (Chronic Alcoholism), Edaravone (Recovery Of Stroke), Etomidate (Anesthetics), Felbamate (Anticonvulsant), Flecainide Acetate (Anti-Arrhythmic Agent), Rifaximin (Antibiotic), S-Ibuprofen (Anti-Inflammatory), Oseltamivir Phosphate(Antiviral) and Levetiracetam (Anticonvulsant). The company provides services, such as synthetic development, analytical development, process engineering, and regulatory services.

Contact

TAMIL NADU
Chennai
3rd & 4th Floor, Batra Centre, No.28, Sardar Patel Road, Guindy
+914443446700
solara.co.in

IPO

2018-06-27

Employees

-

Officers

MD, CEO & Director
Mr. Poorvank Purohit
Chief Financial Officer
Mr. Arun Kumar Baskaran
COO & Executive Director
Mr. Mohan Muthunarayanan
Company Secretary, Compliance Officer & Chief Investor Relations Officer
Mr. Suddapalli Murali Krishna
Founder & Non-Executive Director
Mr. Arun Kumar Pillai B.Com.
Chief Scientific Officer
Dr. Hero Velladurai
Show More
Chief Quality Officer
Mr. V. Sundara Moorthy
Show Less

See Also

Discover More
What is the Intrinsic Value of one SOLARA stock?

The intrinsic value of one SOLARA stock under the Base Case scenario is 539.44 INR.

Is SOLARA stock undervalued or overvalued?

Compared to the current market price of 799.35 INR, Solara Active Pharma Sciences Ltd is Overvalued by 33%.

Back to Top